Chayan Acharya
Chayan Acharya
Senior Consultant, Pharmetheus AB
Verified email at - Homepage
Cited by
Cited by
CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields
K Vanommeslaeghe, E Hatcher, C Acharya, S Kundu, S Zhong, J Shim, ...
Journal of computational chemistry 31 (4), 671-690, 2010
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach
C Acharya, A Coop, J E Polli, A D MacKerell
Current computer-aided drug design 7 (1), 10-22, 2011
An electrostatic mechanism for Ca2+-mediated regulation of gap junction channels
BC Bennett, MD Purdy, KA Baker, C Acharya, WE McIntire, RC Stevens, ...
Nature communications 7, 2016
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo
A Petty, E Myshkin, H Qin, H Guo, H Miao, GP Tochtrop, JT Hsieh, P Page, ...
Public Library of Science 7 (8), e42120, 2012
A diagnostic tool for population models using non-compartmental analysis: The ncappc package for R
C Acharya, AC Hooker, GY Türkyılmaz, S Jönsson, MO Karlsson
Computer methods and programs in biomedicine 127, 83-93, 2016
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter
R Rais, C Acharya, G Tririya, AD MacKerell Jr, JE Polli
Journal of medicinal chemistry 53 (12), 4749-4760, 2010
Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates
R Rais, C Acharya, AD MacKerell Jr, JE Polli
Molecular pharmaceutics 7 (6), 2240-2254, 2010
Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids
PM González, C Acharya, AD MacKerell Jr, JE Polli
Pharmaceutical research 26 (7), 1665-1678, 2009
Pharmacokinetic interactions for drugs with a long half-life—evidence for the need of model-based analysis
EM Svensson, C Acharya, B Clauson, KE Dooley, MO Karlsson
The AAPS Journal 18, 171-179, 2016
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
A Brekkan, L Lopez-Lazaro, G Yngman, EL Plan, C Acharya, AC Hooker, ...
The AAPS journal 20 (5), 91, 2018
Computational Model for Predicting Chemical Substituent Effects on Passive Drug Permeability across Parallel Artificial Membranes†
C Acharya, PR Seo, JE Polli, AD MacKerell Jr
Molecular pharmaceutics 5 (5), 818-828, 2008
Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid
X Zheng, Y Pan, C Acharya, PW Swaan, JE Polli
Bioconjugate chemistry 21 (11), 2038-2048, 2010
PeptiSite: a structural database of peptide binding sites in 4D
C Acharya, I Kufareva, AV Ilatovskiy, R Abagyan
Biochemical and biophysical research communications 445 (4), 717-723, 2014
Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT
V Kolhatkar, L Diao, C Acharya, AD Mackerell Jr, JE Polli
Journal of pharmaceutical sciences 101 (1), 116-126, 2012
A diagnostic tool for population models using non-compartmental analysis: nca_ppc functionality for R
C Acharya, AC Hooker, S Jönsson, MO Karlsson
Annual Meeting of the Population Approach Group in Europe, 2014
Synthesis and Characterization of a Novel Diels–Alder Adduct of Codeine
CW Cunningham, K Hom, C Acharya, A Wilks, AD MacKerell, A Coop
Helvetica chimica acta 93 (2), 220-226, 2010
Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus
C Acharya, MO Magnusson, P Vajjah, R Oliver, M Zamacona
The Journal of Clinical Pharmacology 63 (4), 435-444, 2023
Shiny_ncappc, A Shiny App For Non-compartmental Analysis (nca).
J Hibma, L Fostvedt, C Acharya, A Ruiz-Garcia
Clinical Pharmacology & Therapeutics 99, S69, 2016
The system can't perform the operation now. Try again later.
Articles 1–18